{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-019734","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.702830+00:00","generated_at":"2026-05-17T02:12:57.126804+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"DSS BioHealth converts Series A Preferred into 60.5M common shares of Impact BioMedical","bullets":["DSS BioHealth Security converted its Series A Convertible Preferred Stock into 60,496,041 shares of common stock.","Conversion was elected under Section 6 of the Certificate of Designation, effective after 75-day holding period.","The converted shares represent a significant increase in diluted share count, potentially impacting existing shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-019734","json":"https://secwatch.observer/filing/0001493152-25-019734.json","markdown":"https://secwatch.observer/filing/0001493152-25-019734.md","text":"https://secwatch.observer/filing/0001493152-25-019734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315225019734/0001493152-25-019734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315225019734/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:12:57.126804+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}